Dow AgroSciences Monsanto Licenses Dow AgroSciences Gene-Editing Tech for Agricultural Use The technology is based on engineered zinc finger DNA-binding proteins, which bind to specific functional domains to create transcription factors capable of activating or repressing target genes. Genome Canada Announces Funding for Industry, Academic Research Partnerships The funding will support support two alliances between industry and academia that are applying genomic technologies to agriculture and healthcare. Dow AgroSciences, Radiant Genomics Expand R&D Collaboration The deal expands the companies' ongoing collaboration, which began in mid-2015, to include additional natural product targets in crop protection and traits. Dow AgroSciences, Critical Path Services Reach License Agreement Critical Path will license Dow AgroScience's Plextein technology for multiplex detection of plant proteins using mass spectroscopy and provide it as a service. Dow AgroSciences Inks Deal for Rice Genome-Editing Technology in China The company will work with the Institute of Crop Sciences of the Chinese Academy of Agricultural Sciences to develop the technology into a rice genome-editing platform. May 29, 2015 Dow AgroSciences Publishes New Data on Use of RNAi Against Corn Pest Premium Apr 2, 2015 Dow AgroSciences, Radiant Genomics Form R&D Collaboration Jul 31, 2014 Genomics in the Journals: Arrays 2014.07.31 May 22, 2014 Sigma-Aldrich to Supply ZFN Reagents for Dow AgroSciences Sep 6, 2013 String of Recent Deals Suggests Ag-Bio Market an Opportunity for Chemical Proteomics Firms Premium Jul 9, 2013 Evotec, Dow AgroSciences Enter Proteomics Service Deal Apr 25, 2013 Through Licensing Deal, Dow AgroSciences Gains Access to Monsanto RNAi Tech Premium Aug 31, 2012 Dow Partners with Victoria's Ag Research Department Aug 17, 2012 In Brief This Week: Myriad Genetics; Sequenta; Dow AgroSciences; EA, Illumina, Golden Helix Jul 18, 2011 Dow AgroSciences Grants License to Danforth Center to Improve Cassava Crop May 2, 2011 Dow, Oregon State University Partner on Gene Modification Aug 6, 2010 Dow AgroSciences, Syngenta Sign on as First Corporate Sponsors for TAIR Premium Jan 15, 2010 In Brief This Week: Response Genetics, Dow AgroSciences, Monsanto, Stokes Bio, Cellectis, Sage Bionetworks, HairDx Nov 13, 2009 In Brief This Week: Dow AgroSciences; Chromatin; OriGene Technologies; Jubliant Biosys; Pacific Biosciences; CamStar Systems Breaking News FDA Revises SARS-CoV-2 Test Emergency Use Authorization Requirements to Account for Variants Geisinger Wins $5M NIH Grant to Develop Point-of-Care Genetic Diagnostic Tool Second Genome, Virginia Commonwealth University Partner on NASH Biomarker Discovery LGC Receives CE Mark for AccuPlex SARS-CoV-2, Flu A/B, RSV Reference Material Kit Esophageal Cancer Testing Firm Lucid Diagnostics Files For IPO Twist Bioscience, DeepCDR Collaborate on Antibody Library Design The Scan Booster for At-Risk The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk. Preprints OK to Mention Again Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications. Hundreds of Millions More to Share The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post. Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.